It is a known fact that the body’s immune system plays a key role in cancer diseases through its ability to recognize and destroy tumor cells. This is done, for example, by certain types of white blood cells, called lymphocytes. Increased knowledge of the correlation between the immune system and cancer is of vital importance to understanding how cancer arises and how it affects the immune system, which could potentially lead to new and better treatment methods.
“The findings from this research could contribute to the future development of better treatment of patients suffering from leukemia,” says Professor Eva Forssell-Aronsson, Executive Member of the Assar Gabrielsson Foundation (dedicated to research against cancer diseases).
In his dissertation at Gothenburg University, Johan Aurelius studied the function of two types of lymphocytes in connection with leukemia. He has, for example, proven that cancer cells weaken the immune system by destroying white blood cells, and that this can be prevented by strengthening the white blood cells so that they are capable of resisting the cancer cells. Such treatment could reduce the risk of leukemia relapse.
Assar Gabrielsson was one of the founders of Volvo. In accordance with his wishes, a fund for clinical research into cancer diseases was established. The Assar Gabrielsson Award also includes the opportunity to receive a research grant of SEK 100,000. Over the years, AB Volvo has contributed to the fund’s capital and the fund is now able to contribute more than SEK 4 M annually in research grants to young cancer researchers.
April 26, 2013
Journalists who would like further information, please contact:
Professor Eva Forssell-Aronsson, Executive Member of Assar Gabrielsson Foundation.
tel: +46 703-72 26 26.
Read more about Assar Gabrielsson Foundation at
www.agfond.se/
Image from Volvo’s image gallery
